Carson Wealth (CWM LLC)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$469K Buy
15,579
+8,117
+109% +$261K ﹤0.01% 2065
2025
Q4
$233K Buy
7,462
+2,101
+39% +$51.8K ﹤0.01% 2449
2025
Q3
$108K Buy
5,361
+366
+7% +$6.43K ﹤0.01% 2926
2025
Q2
$84K Buy
4,995
+767
+18% +$12.4K ﹤0.01% 2871
2025
Q1
$65K Buy
4,228
+148
+4% +$2.64K ﹤0.01% 2756
2024
Q4
$90K Sell
4,080
-112
-3% -$2.04K ﹤0.01% 2357
2024
Q3
$76K Buy
4,192
+126
+3% +$2.21K ﹤0.01% 2373
2024
Q2
$66K Buy
4,066
+395
+11% +$6.08K ﹤0.01% 2274
2024
Q1
$52K Buy
3,671
+420
+13% +$5.29K ﹤0.01% 2278
2023
Q4
$34K Buy
3,251
+362
+13% +$3.38K ﹤0.01% 2423
2023
Q3
$29K Buy
2,889
+896
+45% +$8.34K ﹤0.01% 2434
2023
Q2
$15K Sell
1,993
-95
-5% -$770 ﹤0.01% 2840
2023
Q1
$18K Sell
2,088
-102
-5% -$1.01K ﹤0.01% 2589
2022
Q4
$20K Buy
2,190
+163
+8% +$1.42K ﹤0.01% 2385
2022
Q3
$16K Buy
2,027
+204
+11% +$1.8K ﹤0.01% 2396
2022
Q2
$14K Buy
1,823
+200
+12% +$1.74K ﹤0.01% 2387
2022
Q1
$15K Sell
1,623
-147
-8% -$1.23K ﹤0.01% 2265
2021
Q4
$14K Buy
+1,770
New +$16K ﹤0.01% 2183
2021
Q2
$11K Hold
1,105
﹤0.01% 2075
2021
Q1
$11K Hold
1,105
﹤0.01% 2074
2020
Q4
$11K Hold
1,105
﹤0.01% 2073
2020
Q3
$11K Hold
1,105
﹤0.01% 2072
2020
Q2
$11K Hold
1,105
﹤0.01% 2071
2020
Q1
$11K Hold
1,105
﹤0.01% 2071
2019
Q4
$11K Hold
1,105
﹤0.01% 2071
2019
Q3
$11K Hold
1,105
﹤0.01% 2071
2019
Q2
$11K Hold
1,105
﹤0.01% 2071
2019
Q1
$11K Sell
1,105
-6,433
-85% -$113K ﹤0.01% 2071
2018
Q4
$116K Buy
7,538
+1,236
+20% +$25.3K ﹤0.01% 698
2018
Q3
$136K Buy
6,302
+6,300
+315,000% +$146K ﹤0.01% 577
2018
Q2
$0 Sell
2
-63
-97% -$1.28K ﹤0.01% 1776
2018
Q1
$1K Sell
65
-2
-3% -$39 ﹤0.01% 1333
2017
Q4
$1K Sell
67
-300
-82% -$4.51K ﹤0.01% 1399
2017
Q3
$6K Sell
367
-4,244
-92% -$95.5K ﹤0.01% 1041
2017
Q2
$153K Sell
4,611
-1,400
-23% -$43.3K 0.01% 338
2017
Q1
$193K Sell
6,011
-58,050
-91% -$1.98M 0.01% 294
2016
Q4
$2.32M Buy
64,061
+652
+1% +$26K 0.14% 140
2016
Q3
$2.92M Buy
63,409
+24,400
+63% +$1.27M 0.2% 125
2016
Q2
$1.96M Buy
+39,009
New +$2.08M 0.14% 154
2016
Q1
Sell
-136
Closed -$9K 812
2015
Q4
$9K Sell
136
-79
-37% -$4.88K ﹤0.01% 480
2015
Q3
$12K Buy
+215
New +$13.9K ﹤0.01% 432

Other funds holding TEVA

Carson Wealth (CWM LLC)'s TEVA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Teva Pharmaceuticals (TEVA) stake by 109% in Q1 2026, buying an estimated $261K and bringing the position to 15,579 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Carson Wealth (CWM LLC) first reported a position in TEVA in Q3 2015 and has held it in 41 quarters since. The position peaked at $2.92M in Q3 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 15,579 shares of Teva Pharmaceuticals worth $469K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 8,117 Teva Pharmaceuticals shares in Q1 2026, an estimated $261K.
  • Teva Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2065 holding.
  • Carson Wealth (CWM LLC) first reported a position in Teva Pharmaceuticals in Q3 2015 and has held it in 41 quarters since.
  • Carson Wealth (CWM LLC)'s Teva Pharmaceuticals position peaked at $2.92M in Q3 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.